Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2017-05-25 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
关于第一期员工持股计划实施的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of the company's first employee stock ownership plan implementation. It details stock purchases, transaction amounts, and compliance with regulatory requirements. It does not contain financial statements or comprehensive financial data, nor is it a report or presentation. It is a specific update on capital transactions related to employee stock ownership. Therefore, it fits best under Capital/Financing Update (CAP). The document length is short and focused on stock purchase details, not a full report or announcement of a report publication.
2017-05-25 Chinese
重大资产重组进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of a major asset restructuring by the company 三诺生物传感股份有限公司. It mentions the stock suspension due to the ongoing major asset reorganization and references regulatory rules related to major asset restructuring disclosures. The document is relatively short (841 characters) and serves as a progress update rather than a full detailed report or financial statement. It does not contain financial data or detailed analysis but is an official announcement about the status of a capital restructuring event. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2017-05-23 Chinese
关于召开2017年第二次临时股东大会的提示性公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement regarding the convening of the 2017 second extraordinary general meeting of shareholders for 三诺生物传感股份有限公司. It includes information about the meeting date, voting procedures (both in-person and online), agenda items for shareholder approval (notably a restricted stock incentive plan), registration details, and proxy forms. The content is focused on informing shareholders about the meeting logistics and agenda, rather than presenting financial results or management discussion. There is no financial data or report content, but rather a formal notice and instructions for participation in the shareholder meeting. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which are materials sent to shareholders to provide information and request votes for meetings. The document length (7630 characters) and detailed procedural content support this classification rather than a simple announcement or a full report.
2017-05-22 Chinese
监事会关于2017年限制性股票激励计划激励对象人员名单的审核意见及公示情况说明
Regulatory Filings Classification · 95% confidence The document is a formal announcement from the Supervisory Board of SanNuo Biological Sensor Co., Ltd. regarding the review and public disclosure of the list of incentive recipients under the 2017 restricted stock incentive plan. It discusses compliance with relevant laws and regulations, the qualifications of the incentive recipients, and the public notice period. The document does not contain financial statements or detailed financial data, nor is it a report like an annual or interim report. It is not a proxy solicitation or voting result announcement. Instead, it is an official announcement related to the company's equity incentive plan and the supervisory board's review opinion and public disclosure. This type of document fits best under Regulatory Filings (RNS), as it is a regulatory announcement about compliance and disclosure related to stock incentive plans, without being a full report or financial statement.
2017-05-22 Chinese
董事会关于重大资产重组停牌公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from the board of directors of 三诺生物传感股份有限公司 regarding the suspension of trading due to a major asset restructuring. It details the background of the restructuring, the involved parties, the planned issuance of shares to purchase assets, and the regulatory compliance and timeline for disclosure. The document does not contain financial statements or detailed financial analysis but rather informs about the trading suspension and the progress of the restructuring process. It is a formal notice related to a major asset reorganization and trading suspension, which fits the category of Capital/Financing Update (CAP) as it involves issuance of shares and capital structure changes related to asset acquisition. The document length is short (1970 characters), and it is not a report publication announcement or a certification. Therefore, the best classification is CAP with high confidence.
2017-05-16 Chinese
2016年年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the implementation of the 2016 annual equity distribution plan by 三诺生物传感股份有限公司. It details the dividend distribution, share transfer, record dates, and other related shareholder information. The document is relatively short (2981 characters) and focuses on the dividend payment and share capital changes following shareholder approval at the 2016 annual general meeting. It does not contain comprehensive financial statements or detailed financial performance data. This type of document is a formal announcement of dividend distribution and share capital changes, fitting the category of Notice of Dividend Amount (DIV).
2017-05-12 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.